ivabradine has been researched along with Cancer of Pituitary in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Lu, TJ; Lu, TL; Wu, SN | 1 |
Hsiao, HT; Liu, PY; Liu, YC; Wu, SN | 1 |
2 other study(ies) available for ivabradine and Cancer of Pituitary
Article | Year |
---|---|
Inhibitory Effective Perturbations of Cilobradine (DK-AH269), A Blocker of HCN Channels, on the Amplitude and Gating of Both Hyperpolarization-Activated Cation and Delayed-Rectifier Potassium Currents.
Topics: Animals; Benzazepines; Cations; Cell Line, Tumor; Hyperpolarization-Activated Cyclic Nucleotide-Gated Channels; Ion Transport; Ivabradine; Kinetics; Patch-Clamp Techniques; Piperidines; Pituitary Neoplasms; Potassium; Shab Potassium Channels; Sodium | 2020 |
Concerted suppression of I
Topics: Action Potentials; Animals; Cell Line, Tumor; Endocrine Cells; Hippocampus; Humans; Hyperpolarization-Activated Cyclic Nucleotide-Gated Channels; Ivabradine; Membrane Potentials; Mice; Neurons; Pituitary Neoplasms; Potassium Channels | 2019 |